13 results
PRE 14A
ADVM
Adverum Biotechnologies Inc
14 Apr 23
Preliminary proxy
6:03am
the 2023 Annual Meeting by board independence, non-employee status, and tenure of service (as of April 15, 2023), as well as the skills and experience … . Machado’s tenure on the Board, his experience in serving on multiple other biotechnology company boards, as well as the deep knowledge of our company
DFAN14A
Sonic Fund II, L.P.
4 May 21
Additional proxy materials by non-management
10:11am
that of its gene therapy peers, notwithstanding the read through effect of ostensibly unrelated developments.”
“During the tenure of the newly appointed CEO
DEFA14A
68jr7 p2o825
15 Apr 21
Additional proxy soliciting materials
8:59am
DEFC14A
u6dflbjtgcou0
15 Apr 21
Proxy in contested solicitation
6:03am
PRER14A
pij79rz0f54 gd
7 Apr 21
Preliminary revised proxy
4:28pm
PREC14A
uqlhazf91mz7zhlk
5 Apr 21
Preliminary proxy with contested solicitation
5:27pm
DEFA14A
czcsefr ei
17 Mar 21
Additional proxy soliciting materials
5:28pm
8-K
EX-99.1
ej1qb75580eroerxxj
1 Mar 21
Results of Operations and Financial Condition
4:04pm
- Prev
- 1
- Next